The role of NFkB in (1-->3)-B-glucan (Zymosan A) induced TNF-alpha production.
Authors
Young S; Ye J; Frazer DG; Shi X; Castranova V
Source
Proceedings of the 24th Cotton and Other Organic Dusts Research Conference, January 7-8, 2000, San Antonio, TX, Wakelyn-PJ, Jacobs-RR, Rylander-R, eds., Memphis, TN: The National Cotton Council, 2000 Jan; :15
Link
NIOSHTIC No.
20021101
Abstract
The signal transduction pathway in the inflammatory response caused by a fungal cell wall component (1-->3)-B-glucan is not well understood. The present study used zymosan A-induced tumor necrosis factor (TNF)-alpha production as a model to explore the signal transduction pathway for B-glucan stimulation in RAW264.7 cells. Zymosan A increased TNF-alpha production in RAW264.7 cells in a time and concentration dependent pattern with the optimal time and concentration occurring at 23 hr and 100 ug/mL zymosan A, respectively. A gel shift assay was used to examine the DNA-binding activity of NFkB in the zymosan A- treated cells. This NFkB activity was enhanced by this stimulant. NFkB activation was associated with TNF-alpha production, since the cells pre-treated with a known NFkB inhibitor (caffeic acid phenethyl ester) decreased both NFkB activation and TNF-alpha production. The dependence of TNF-alpha transcriptional initiation on kB sites was investigated using a luciferase reporter assay. Both wild type and kB-mutated type TNF-alpha promoters were utilized to study the dependence of TNF-alpha promoter on kB sites. The results demonstrated that the activation of TNF-alpha promoter was dependent on the activation of NFkB. A NFkB specific reporter was used in conjunction with TNF-alpha wild type reporter to evaluate the temporal relationship between the NFkB activation and induction of TNF-alpha reporter activity. The results showed that the peak of NFkB activation occurred at 5 hrs which proceeded the peak of TNF-alpha promoter activation (30 hrs). The above results suggest that activation of NFkB is one of the pathways involved in zymosan A-induced TNF-alpha production.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.